1. Mitochondrial MDM2 regulates respiratory complex i activity independently of p53
- Author
-
Kevin Nay, Romain Riscal, Christelle Bertrand-Gaday, Craig E. Cameron, Christelle Koechlin-Ramonatxo, Madi Y. Cissé, Laurent Le Cam, Béatrice Chabi, Béatrice Orsetti, Laetitia K. Linares, Kerren Murray, Charles Vincent, Hervé Dubouchaud, Laurie Gayte, Markus Kastner, Samuel Pyrdziak, Florence Bernex, Giuseppe Arena, Miria Ricchetti, François Casas, Laurent Chatre, Claire Angebault-Prouteau, Maryse Fuentes, Sandrine Etienne-Manneville, Anne Lombès, Jamie J. Arnold, Jean-Christophe Marine, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Cellules Souches et Développement / Stem Cells and Development, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Pennsylvania State University (Penn State), Penn State System, Dynamique Musculaire et Métabolisme (DMEM), Institut National de la Recherche Agronomique (INRA)-Université de Montpellier (UM), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Polarité cellulaire, Migration et Cancer - Cell Polarity, Migration and Cancer, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), VIB [Belgium], BioCampus Montpellier (BCM), Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratory of Fundamental and Applied Bioenergetics = Laboratoire de bioénergétique fondamentale et appliquée (LBFA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), This research was supported by grants from the Ligue contre le Cancer (Equipe labelisée 2016), the French National Health Institute for Biomedical Research (INSERM), the French National Cancer Institute (INCa), the General Direction for Care Provision (grant INCa-DGOS-Inserm 6045), and The Laboratory of Excellence EpiGenMed, ANR-10-LABX-0012,EpiGenMed,From Genome and Epigenome to Molecular Medicine: turning new paradigms in biology into the therapeutic strategies of tomorrow(2010), Cellules Souches et Développement, Université de Montpellier (UM)-Institut National de la Recherche Agronomique (INRA), Polarité cellulaire, Migration et Cancer / Cell Polarity, Migration and Cancer, Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Laboratoire de bioénergétique fondamentale et appliquée (LBFA), Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes (UGA), This research was supported by grants from the Ligue contre le Cancer (Equipe labelisée 2016), the French National Health Institute for Biomedical Research (INSERM), the French National Cancer Institute (INCa), the General Direction for Care Provision (grant INCa-DGOS-Inserm 6045), and The Laboratory of Excellence EpiGenMed (grant ANR-10-LABX-12-01), ANR-10-LABX-0012/10-LABX-0012,EpiGenMed,From Genome and Epigenome to Molecular Medicine: turning new paradigms in biology into the therapeutic strategies of tomorrow(2010), ProdInra, Archive Ouverte, Laboratoires d'excellence - From Genome and Epigenome to Molecular Medicine: turning new paradigms in biology into the therapeutic strategies of tomorrow - - EpiGenMed2010 - ANR-10-LABX-0012 - LABX - VALID, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), BioCampus (BCM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Radiothérapie moléculaire (UMR 1030), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Perelman School of Medicine, University of Pennsylvania [Philadelphia], Laboratoire Mouvement Sport Santé (M2S), École normale supérieure - Cachan (ENS Cachan)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université de Brest (UBO)-Université de Rennes 2 (UR2), Université de Rennes (UNIV-RENNES)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Perception et Mémoire, Institut national de la recherche agronomique [Montpellier] (INRA Montpellier), Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1), Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de Génétique Humaine, Université Catholique de Louvain (UCL), Génétique Moléculaire et Cellulaire (UGMC), École nationale vétérinaire d'Alfort (ENVA)-Institut National de la Recherche Agronomique (INRA), Université Grenoble Alpes (UGA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Joseph Fourier - Grenoble 1 (UJF), Génétique Moléculaire des Levures, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Université Montpellier 1 (UM1), Institut de Génétique Moléculaire de Montpellier (IGMM), and Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Mitochondrial ROS ,Lung Neoplasms ,Transcription, Genetic ,[SDV]Life Sciences [q-bio] ,translocation ,Biochemistry, biophysics & molecular biology [F05] [Life sciences] ,Mitochondrion ,dna ,migration ,medicine.disease_cause ,Adenocarcinoma/genetics/metabolism/pathology ,Mice ,Cell Movement ,Carcinoma, Non-Small-Cell Lung ,Tumor Cells, Cultured ,Carcinoma, Non-Small-Cell Lung/genetics/metabolism/pathology ,Biochimie, biophysique & biologie moléculaire [F05] [Sciences du vivant] ,ComputingMilieux_MISCELLANEOUS ,Mice, Knockout ,biology ,Proto-Oncogene Proteins c-mdm2/genetics/metabolism ,apoptosis ,Proto-Oncogene Proteins c-mdm2 ,Cell biology ,Mitochondria ,Electron Transport Complex I/genetics/metabolism ,mitochondria ,[SDV] Life Sciences [q-bio] ,Gene Expression Regulation, Neoplastic ,medicine.anatomical_structure ,Cell Transformation, Neoplastic ,Mdm2 ,MT-ND6 ,transcription ,Signal Transduction ,respiratory complex I ,[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,Adenocarcinoma ,Cell Transformation, Neoplastic/genetics/metabolism/pathology ,Article ,Mitochondria/genetics/metabolism/pathology ,03 medical and health sciences ,MDM2 ,medicine ,Animals ,Humans ,metastasis ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Neoplasm Invasiveness ,skeletal muscle ,Molecular Biology ,Lung Neoplasms/genetics/metabolism/pathology ,Electron Transport Complex I ,hypoxia ,Skeletal muscle ,Cell Biology ,Xenograft Model Antitumor Assays ,initiation ,Mice, Inbred C57BL ,Oxidative Stress ,030104 developmental biology ,Apoptosis ,Tumor progression ,Tumor Suppressor Protein p53/genetics/metabolism ,Genome, Mitochondrial ,biology.protein ,activation ,Tumor Suppressor Protein p53 ,protein import ,Carcinogenesis - Abstract
International audience; Accumulating evidence indicates that the MDM2 oncoprotein promotes tumorigenesis beyond its canonical negative effects on the p53 tumor suppressor, but these p53-independent functions remain poorly understood. Here, we show that a fraction of endogenous MDM2 is actively imported in mitochondria to control respiration and mitochondrial dynamics independently of p53. Mitochondrial MDM2 represses the transcription of NADH-dehydrogenase 6 (MT-ND6) in vitro and in vivo, impinging on respiratory complex I activity and enhancing mitochondrial ROS production. Recruitment of MDM2 to mitochondria increases during oxidative stress and hypoxia. Accordingly, mice lacking MDM2 in skeletal muscles exhibit higher MT-ND6 levels, enhanced complex I activity, and increased muscular endurance in mild hypoxic conditions. Furthermore, increased mitochondrial MDM2 levels enhance the migratory and invasive properties of cancer cells. Collectively, these data uncover a previously unsuspected function of the MDM2 oncoprotein in mitochondria that play critical roles in skeletal muscle physiology and may contribute to tumor progression.
- Published
- 2018